BIO

BIO-RAD LABORATORIES, INC.

Laboratory Analytical Instruments · SIC 3826CIK 12208Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$2.58B

Net Income FY2025

$0.76B

EPS (Basic, as reported)

$27.87

Net Margin FY2025

29.4%

ROE FY2025

10.2%

Total Equity

$7.45B

Shares Out

28M

Business description

BIO-RAD LABORATORIES, INC. — Laboratory Analytical Instruments. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2008–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 2,068 → 2,583 +2.5% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue2,0682,1602,2892,3122,5462,9232,8022,6712,5672,583

Cost of revenue(930)(972)(1,066)(1,055)(1,108)(1,282)(1,235)(1,244)(1,188)(1,243)

Gross profit1,1381,1871,2231,2571,4381,6411,5671,4271,3791,340

Research & development(206)(250)(199)(203)(227)(272)(257)(247)(296)(276)

Selling, general & administrative(817)(809)(835)(825)(800)(880)(828)(842)(814)(844)

Operating income53117(103)23041148948333826947

Interest expense(22)(22)(24)(23)(22)(2)(38)(49)(49)(49)

Interest & investment income151927311819581018296

Other income (expense), net01237262427451069090

Pre-tax income42985132,2614,9085,438(4,704)(850)(2,342)996

Income tax expense(13)(24)(147)(502)(1,101)(1,192)(1,077)(213)(498)(236)

Net income281223661,7593,8064,246(3,628)(637)(1,844)760

EPS — basic$0.96$4.12$12.25$58.93$127.86$142.33($121.79)($21.82)($65.36)$27.87

EPS — diluted$0.95$4.07$12.10$58.27$126.20$140.56($121.79)($21.82)($65.36)$27.85

Shares outstanding — basic (M)29303030303030292827

Shares outstanding — diluted (M)30303030303030292827

Showing the latest 10 of 18 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.